Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04289740
Other study ID # PsicAP-A
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date April 1, 2022
Est. completion date April 1, 2023

Study information

Verified date March 2022
Source Instituto de Investigación Marqués de Valdecilla
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Emotional disorders such as anxiety and depression are highly prevalent during adolescence and associated with functional impairment that commonly extends into adulthood. In the primary care (PC) setting, these disorders are frequently underdiagnosed and undertreated. Objective: To carry out a prospective, randomized controlled trial (RCT) to test the efficacy of a new transdiagnostic cognitive behavioural group therapy (TD-CBT) protocol for adolescents (age 12 to 18 years) compared to group relaxation therapy (RT). Methods: Two-arm, single-blind, RCT (expected N=160) to compare group TD-CBT for emotional disorders to group RT. The group TD-CBT will be administered in seven sessions (90 min/session) over 12 weeks. Psychological assessments will be carried out at baseline, post-treatment, and at months 3, 6, and 12 after treatment. The assessments will include measures of depression, anxiety, somatization, quality of life, disability, and cognitive-emotional factors. The study will be conducted in two PC centres located in Cantabria, Spain. Discussion: This is the first RCT to evaluate the efficacy of group TD-CBT for emotional disorders in adolescents in the PC setting in Spain. If, as expected, the results confirm the superiority of TD-CBT to conventional RT, the widespread implementation of this new approach-based on scientific evidence obtained in a real-world, primary care setting-could improve treatment outcomes and quality of life in adolescents suffering from anxiety or depression.


Recruitment information / eligibility

Status Recruiting
Enrollment 160
Est. completion date April 1, 2023
Est. primary completion date April 1, 2023
Accepts healthy volunteers No
Gender All
Age group 12 Years to 18 Years
Eligibility Inclusion Criteria: - Patients aged 12 to 17, inclusive, who present to the PC centre seeking treatment for symptoms of anxiety or depression. - Scores above the predetermined cut-off points on the GAD-7 (>= 5) and PHQ-9 (>= 5). - Agreement to participate in the study, with written informed consent provided by both patients and parents/guardians. Exclusion Criteria: - Presence of any severe mental disorder, including autism spectrum disorders, bipolar disorder, schizophrenia, anorexia nervosa, substance dependence, personality disorder, and major depressive disorder (PHQ-9> 20). - Presence of severe or recent suicide attempts - Moderate or severe behaviour disorder that could interfere with the dynamics of the therapy groups. - Presence of a mental disability (IQ < 75). - Be receiving psychological treatment or any type of specialized care related to mental health. - Receiving any psychopharmacological treatment. - Parents involved in legal litigation due to separation or divorce.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
7 sessions (1.5 hr/session) in groups of approximately 8-10 individuals
Patients assigned to the experimental group will receive 7 sessions (1.5 hr/session) in groups of approximately 8-10 individuals over a 12 week period
a progressive muscle relaxation group intervention, based on the Bernstein and Borkoveck procedure plus same number of sessions as the experimental intervention.
The control group will receive a progressive muscle relaxation group intervention, based on the Bernstein and Borkoveck procedure. This intervention will have the same number of sessions as the experimental intervention and last anywhere from 60 to 90 minutes, depending on the session.

Locations

Country Name City State
Spain centro salud mental Girones Girona
Spain Centro Salud Mental Selva Marítima Girona
Spain Hospital de Laredo Laredo
Spain Hospital Sierrallana Torrelavega

Sponsors (3)

Lead Sponsor Collaborator
Instituto de Investigación Marqués de Valdecilla Hospital de laredo, Hospital Sierrallana

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Depressive symptoms Patient Health Questionnaire - 9 item (PHQ-9), adolescent version. Nine items assessing depressive symptoms with Likert response with values ranging from 0 to 3 (Total score range: 0-27; higher scores means a worse outcome) 12 month follow-up period.
Primary Depressive symptoms Children's Depression Inventory, short version (CDI-S). Consists of 10 items answered on a three-point scale, where 0 = absence of the symptom, 1 = moderate symptom, and 2 = severe symptom. The total score ranges from 0 to 20. Higher scores means a worse outcome 12 month follow-up period.
Primary Anxiety symptoms Generalized Anxiety Disorder - 7 item (GAD-7). It is composed of 7 Likert response items, ranging from 0 to 3 points (Total score range: 0-21). Higher scores means a worse outcome. 12 month follow-up period.
Primary Anxiety symptoms Spence Children Anxiety Scale, short version (SCAS-S). It consists of 19 items, ranging from 0 to 3, as follows: 0 = "never", 1 = "sometimes", 2 = "many times", 3 =" always". Total scores range from 0-57 points. Higher scores means a worse outcome. 12 month follow-up period.
Secondary the Quality of life KIDSCREEN-10 index. It is composed of 10 Likert response items, ranging from 1 to 5 points. (Total score range: 10-50). Higher scores means a better outcome. 12 month follow-up period.
Secondary Somatizations PHQ-15. is composed of 15 Likert response items, ranging from 0 to 2 points. (Total score range: 0-30). Higher scores means a worse outcome. 12 month follow-up period.
Secondary Rumination Ruminative Responses Scales (RRS), brooding subscale. It is composed of 5 Likert response items, ranging from 1 to 4 points. (Total score range: 5-20). Higher scores means a worse outcome. 12 month follow-up period.
Secondary Pathological worry Penn State Worry Questionnaire (PSWQ), reduced 8-item version. It is composed of 8 Likert response items, ranging from 1 to 5 points. (Total score range: 5-40). Higher scores means a worse outcome. 12 month follow-up period.
Secondary Attentional and interpretative biases Inventory of Cognitive Activity in Anxiety Disorders (IACTA), abbreviated 5-item version. It is composed of 5 Likert response items, ranging from 0 to 4 points. (Total score range: 0-20). Higher scores means a worse outcome. 12 month follow-up period.
Secondary Emotional regulation Emotion Regulation Questionnaire (ERQ). It is composed of 10 Likert response items, ranging from 1 to 7 points. It assess two emotion-regulation strategies: cognitive reappraisal (6 items; range 6-42; higher scores means a better outcome) and expressive suppression (4 items; range 4-28: higher scores means a worse outcome) 12 month follow-up period.
Secondary Metacognitive beliefs Metacognitions Questionnaire (MCQ-30); the 6-item negative metacognitive beliefs subscale.
It is composed of 6 Likert response items, ranging from 1 to 4 points. (Total score range: 6-24). Higher scores means a worse outcome.
12 month follow-up period.
See also
  Status Clinical Trial Phase
Recruiting NCT04680611 - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Active, not recruiting NCT04935593 - Strengthening Social, Emotional and Behavioral Resilience N/A
Not yet recruiting NCT05225701 - Efficacy of a Transdiagnostic Guided Internet-Delivered Intervention for Emotional, Trauma and Stress-Related Disorders. N/A
Recruiting NCT05172427 - Acceptability/Feasibility of IU Intervention N/A
Recruiting NCT03064477 - The Unified Protocol for the Treatment of Emotional Disorders in Spanish Public Mental Health System N/A
Recruiting NCT05019053 - Acceptability/Feasibility of COVID-19 Intervention N/A
Active, not recruiting NCT04847310 - Cost-benefit Evaluation of a Transdiagnostic Psychological Treatment for Emotional Disorders in Primary Care N/A
Completed NCT04091633 - School Health Implementation Network: Eastern Mediterranean N/A
Not yet recruiting NCT06056232 - Mechanisms of Mindfulness Intervention: Distress Tolerance Dose Manipulation N/A
Recruiting NCT06105567 - The Effect of Education Given According to the Health Promotion Model on Premenstrual Symptoms, Emotional Eating Behavior and Perceived Stress N/A
Recruiting NCT06373484 - Matching Assessment and Treatment for Children With Disruptive Behaviour and Their Parents N/A
Completed NCT05589090 - Super Skills for Life Effectiveness in the Online Modality N/A
Completed NCT03312673 - Asthma, Smoking, Emotional Deficits
Completed NCT03315208 - Study of a Transdiagnostic, Emotion-focused Group Intervention for Young Adults With Substance Use Disorders N/A
Completed NCT04182061 - Internet Transdiagnostic-CBT for Anxiety and Depression in Adolescents N/A
Not yet recruiting NCT05081830 - Online Transdiagnostic Intervention for Emotional Disorders and Stress-related Disorders N/A
Completed NCT04137471 - Validation of the Ontological Addiction Scale
Completed NCT05482724 - Super Skills for Life Effectiveness in Clinical Settings N/A
Terminated NCT03904784 - School Withdrawal in Adolescents
Recruiting NCT06361667 - Culture and Well-being: Art as Prescription Therapy ("Art on Prescription") N/A